Evidence map›Paper›PMID 37470930›Full record

ArticlePhysical and engineering sciences in medicine2023

Development of open access tool for automatic use factor calculation using DICOM-RT patient data.

Dong Hyeok Choi, Dong Wook Kim, So Hyun Park, So Hyun Ahn, Woo Sang Ahn, Rena Lee, Jin Sung Kim

Abstract read
In one paragraph

Article in Physical and engineering sciences in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dong Hyeok Choi *Department of Medicine, Yonsei University College of Medicine, Seoul, Korea.
Dong Wook Kim *Department of Medicine, Yonsei University College of Medicine, Seoul, Korea.
So Hyun ParkDepartment of Radiation Oncology, Jeju National University Hospital, Jeju University College of Medicine, Jeju, Republic of Korea.
So Hyun AhnEwha Medical Research Institute, School of Medicine, Ewha Womans University, Seoul, Republic of Korea. mpsohyun@gmail.com.ORCID http://orcid.org/0000-0002-0116-3325
Woo Sang AhnDepartment of Radiation Oncology, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea. anidol@ulsan.ac.kr.
Rena LeeDepartment of Biomedical Engineering, School of Medicine, Ewha Womans University, Seoul, South Korea.
Jin Sung KimDepartment of Medicine, Yonsei University College of Medicine, Seoul, Korea.

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF) 2022R1H1A2092091Future innovation-based technology radiation research RS-2022-00144201Gangneung Asan Hospital 2021IC003Korea Foundation of Nuclear Safety (KOFONS) 2205013-0122-CG100Korea Institute of Energy Technology Evaluation and Planning 20227410100050
6 · The paper itself

Abstract

Our study recalculated the use factor of linear accelerators (LINACs) by using an in-house program based on Digital Imaging and Communications in Medicine radiation therapy (DICOM-RT). We considered the impact of advancements and changes in treatment trends, including modality, technology, and radiation dose, on the use factor, which is one of the shielding parameters. In accordance with the methodology described in the NCRP 151 report, we computed the use factor for four linear accelerators (LINACs) across three hospitals. We analyzed the results based on the treatment techniques and treatment sites for three-dimensional conformal radiation therapy (3D-CRT) and intensity modulated radiation therapy or volumetric modulated arc therapy. Our findings revealed that the use factors obtained at 45° and 90° were 14.8% and 13.5% higher than those of the NCRP 151 report. In treatment rooms with a high 3D-CRT ratio, the use factor at a specific angle differed by up to 14.6% relative to the NCRP 151 report value. Our results showed a large difference in the use factor for specific sites such as the breast and spine, so it is recommended that each institution recalculate the use factor using patient's data.

Indexed as

Radiotherapy, ConformalRadiotherapy, Intensity-ModulatedAccess to InformationHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedDICOM-RTLINACMonitor unitNCRP 151Shielding evaluationUse factor

Identifiers

PMID37470930
PMCPMC10480328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.